Official Journal of Research Center for Gastroenterology and Liver Diseases
Authors
1,*, Andrzej Tretyn3, Waldemar Halota1, Malgorzata Tyczyno1, Dorota Kozielewicz1, Dorota Dybowska1Three single nucleotide polymorphisms (SNPs) near interleukin-28B (IL-28B) gene were shown to be highly associated with treatment response (SVR) in patients with chronic hepatitis C virus (HCV) infection. There is limited data about the role of single and combined IL-28B polymorphisms in HCV-infected Polish population.
This study's aim was to determine predictability of three IL-28B gene polymorphisms and other known prognostic factors on the treatment response in HCV genotype 1 and 4 infected Polish patients. The effect of IL-28B polymorphisms on therapy was also compared with other known prognostic factors.
We genotyped IL-28B polymorphisms (rs12979860, rs12980275 and rs8099917) by polymerase chain reaction-based restriction fragment length polymorphism assay in a group of 293 patients from which a selected cohort of 174 treatment-nave patients underwent treatment.
We showed that rs12979860 CC [odds ratio (OR) = 4.6, P < 0.001], rs12980275 AA (OR = 2.9, P = 0.002) and rs8099917 TT (OR = 2.2, p = 0.016) genotypes were associated with successful treatment compared to the rs12979860 CT-TT, rs12980275 AG-GG and rs8099917 TG-GG, respectively. Patients bearing of IL28B profile including the three favourable genotypes do not have much chance of a recovery (OR = 3.4, P = 0.002). Except for IL-28B polymorphisms, there was no association of SVR with any other pretreatment clinical data in analyzed group. The correlation of SNPs with other host and viral factors revealed association of favorable genotypes of IL-28B markers with high levels of alanine aminotransferase and baseline HCV viral load.
IL-28B polymorphisms were the strongest pretreatment predictors of response to pegylated interferon and ribavirin in Polish patients chronically infected with HCV genotype 1 and 4. This study confirm the strongest impact of IL-28B rs12979860 on SVR, nevertheless rs12980275 AA seems to be more important than rs8099917 TT in predicting positive treatment response.
© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Bokharaei-Salim F, Salehi-Vaziri M, Sadeghi F, Khanaliha K, Esghaei M, et al. Genetic Variation in Interleukin-28B and Response to Peg-IFNα-2a/RBV Combination Therapy in Patients with Hepatitis C Virus Infection. Jundishapur J Microbiol. 2017;10(1):e39178. doi: https://doi.org/10.5812/jjm.39178
Koolivand M, Allamehzadeh Z, Ahmadi A, Taheri RA, Hassanpour K, et al. The Study of IFNL3 Gene Rs12979860 Polymorphism in the Hepatitis C Virus Patients and Healthy Population in Tehran Province, Iran. Jundishapur J Microbiol. 2020;13(5):e95798. doi: https://doi.org/10.5812/jjm.95798
Zare F, Hadinedoushan H, Akhondi Meybodi M, Dehghanmanshadi M, Mirghanizade Bafghi SA, et al. The Effect of IL28B Gene Polymorphism on Treatment Response in Iranian Patients with Hepatitis C Virus Infection. Jundishapur J Microbiol. 2016;9(12):e31501. doi: https://doi.org/10.5812/jjm.31501
Mi Y, Gao YT, Jiao XL, Guo H, Liu T, et al. The Role of Interleukin-28b Gene Polymorphisms in Chinese Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin. Hepat Mon. 2014;14(8):e18793. doi: https://doi.org/10.5812/hepatmon.18793
Sporea I, Popescu A, Curescu M, Sirli R, Dan I, et al. The Correlation of Il28B Genotype With Sustained Virologic Response In Romanian patients With Chronic Hepatitis C. Hepat Mon. 2011;11(12):. doi: https://doi.org/10.5812/kowsar.1735143X.793
Last Update: 1 week ago
Last Update: 1 week ago
Last Update: 1 week ago
Last Update: 6 hours ago
Last Update: 11 hours ago
Last Update: 5 days ago
